↓ Skip to main content

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

Overview of attention for article published in Drug Safety, April 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
2 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
69 Mendeley
Title
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
Published in
Drug Safety, April 2013
DOI 10.1007/s40264-013-0032-z
Pubmed ID
Authors

Elisabetta Poluzzi, Emanuel Raschi, Ariola Koci, Ugo Moretti, Edoardo Spina, Elijah R. Behr, Miriam Sturkenboom, Fabrizio De Ponti

Abstract

Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 68 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 14%
Student > Ph. D. Student 9 13%
Researcher 8 12%
Other 7 10%
Student > Postgraduate 6 9%
Other 17 25%
Unknown 12 17%
Readers by discipline Count As %
Medicine and Dentistry 19 28%
Pharmacology, Toxicology and Pharmaceutical Science 10 14%
Agricultural and Biological Sciences 6 9%
Psychology 3 4%
Computer Science 3 4%
Other 8 12%
Unknown 20 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2016.
All research outputs
#7,169,915
of 23,866,543 outputs
Outputs from Drug Safety
#763
of 1,730 outputs
Outputs of similar age
#59,376
of 201,787 outputs
Outputs of similar age from Drug Safety
#14
of 32 outputs
Altmetric has tracked 23,866,543 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,730 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,787 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.